CorMedix
CRMD
#6289
Rank
HK$6.47 B
Marketcap
HK$82.21
Share price
-0.75%
Change (1 day)
9.10%
Change (1 year)

Earnings for CorMedix (CRMD)

Earnings in 2025 (TTM): HK$0.83 Billion

According to CorMedix's latest financial reports the company's current earnings are HK$0.21 Billion. In 2024 the company made an earning of -HK$0.16 Billion, an increase over its 2023 earnings that were of -HK$0.37 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CorMedix from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) HK$0.83 B-654.4%
2024 -HK$0.16 Billion-58.3%
2023 -HK$0.37 Billion53%
2022 -HK$0.24 Billion2.81%
2021 -HK$0.23 Billion8.32%
2020 -HK$0.22 Billion26.53%
2019 -HK$0.17 Billion-19.89%
2018 -HK$0.21 Billion-18.72%
2017 -HK$0.26 Billion34.56%
2016 -HK$0.2 Billion34.88%
2015 -HK$0.15 Billion-11.08%
2014 -HK$0.16 Billion124.69%
2013 -HK$70.87 Million144.91%
2012 -HK$28.94 Million-48.41%
2011 -HK$56.09 Million-33.29%
2010 -HK$84.08 Million78.42%
2009 -HK$47.13 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Becton Dickinson
BDX
HK$14.68 B 1,662.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$1.28 B 54.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
HK$0.12 B-85.53%๐Ÿ‡บ๐Ÿ‡ธ USA